Tag: prostate Cancer Screening
-
Prostate Cancer Awareness Month Wraps up
To sum up, the state of prostate cancer care has been a mixed bag for years. We’ve made some strides, but let’s not kid ourselves—there are still hurdles to jump. The future looks bright though. Stay tuned for upcoming posts where we’ll tackle the real issues men face in getting the care they need. Until…
-
Prostate cancer screening event at Overlook Medical Center on October 3, 2013.
I am participating in a prostate cancer screening event for men over 50 years old that would like to be screened for prostate cancer. Men will have a PSA blood draw and a digital rectal examination. The target audience is for men not under the care of a physician currently. The event will be held…
-
Dr. Krieger and Dr. Savatta discuss prostate cancer and PSA screening
In June of 2013 I joined my partner and president of UGNJ, Alan Krieger, MD to educate the public about prostate cancer. Recently a governmental agency recommended against prostate cancer screening with PSA without recommending a replacement for PSA. We had a thorough discussion about the need to screen for prostate cancer and what men…
-
Shared decision-making uncommon for PSA tests | Reuters
They found 64 percent of those men had not discussed the pluses and minuses of PSA tests with their doctors, or the scientific uncertainty of their effect. Of the rest, about half had talked only about the advantages of screening. About 44 percent of study participants hadn’t been screened for prostate cancer in the past…
-
AUA: Five tests, treatments may be unnecessary | Urology Times
The AUA’s list identified the following five recommendations: A routine bone scan is unnecessary in men with low-risk prostate cancer. Do not prescribe testosterone to men with erectile dysfunction who have normal testosterone levels. Do not order creatinine or upper tract imaging in men with BPH. Do not treat an elevated PSA with antibiotics for…
-
They got it wrong again – www.phillyburbs.com: Reader Voices
While prostate cancer is still the second leading cause of death for American men, early detection and advanced treatments have combined to reduce the mortality rate from prostate cancer by nearly 40 percent in the last two decades. During that same time period, we have seen dramatically less metastatic disease than in my earliest days…
-
Prostate Cancer Screening: Moving Beyond PSA – Renal and Urology News
In nearly 1,000 men undergoing initial or repeat biopsy, these investigators found that urinary PCA3 prior to a prostate biopsy improved the prediction of PCa and high-grade disease with a high positive predictive value 90% in the initial biopsy setting and a high negative predictive value 88% in the repeat biopsy setting. The investigators conclude…
-
UroToday – Prospective evaluation of prostate cancer risk in candidates for inguinal hernia repair – Abstract
Prior laparoscopic hernia repair is not a contraindication to robotic prostatectomy.
-
Prostate Biopsy: Side Effects and Risks
UroToday – EAU 2007 – Session on Prostate Biopsy 1 The 7,074 biopsies were performed in 5,153 men. Minor complications included hematuria >1 day (13.8%), hematospermia (35.8%), and rectal bleeding (2.1%). Major complications were prostatitis, epididymitis, fever >38C, rectal bleeding >2 days, and urinary retention, all <1.0%. This study validates the safety of TRUS biopsy…